Non-alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Intervention group 1: Combined exercise, training intervention will be done 3 sessions per week for 60 minutes. Each session consists of 3 parts of practice, 5 part
Sponsors
Shahed University
Eligibility
Sex/Gender
Male
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Middle-aged men 30 to 60 years Grade 1, 2 and 3 liver disease People with high blood lipid profiles People without cardiovascular disease People without physical disabilities
Exclusion criteria
Exclusion criteria: Men over 60 years old People with fatty liver disease grade 4 People with physical disabilities People with heart failure People with lung disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of hepatic alanine transaminase and aspartate transaminase enzymes. Timepoint: Measurement three days before the start of the study intervention. Method of measurement: Blood test to determine the serum levels of alanine transaminase and aspartate transaminase liver enzymes is performed by BT 2500 analyzer and 3000 rpm centrifuge for 5 minutes with Behdad device made in Iran and standard kits of Par Azmoon company.;Liver grade. Timepoint: Measurement three days before the start of the study intervention. Method of measurement: Liver grade with ultrasound device from Samsung Korea WS80A model.;Blood lipid profile. Timepoint: Measurement three days before the start of the study intervention. Method of measurement: Blood test to determine the amount of blood lipid profile is measured by BT 2500 analyzer and 3000 rpm centrifuge in 5 minutes with Behdad device made in Iran and standard kits of Par Azmoon company.;Motor function. Timepoint: Measurement three days before the start of the study intervention. Method of measurement: Motor function is performed by fitness tests (sit-ups, steps, stork balance, quadratic agility, and Welsh flexibility). | — |
Secondary
| Measure | Time frame |
|---|---|
| Decreased hepatic alanine transaminase and aspartate transaminase enzymes. Timepoint: Measurement three days after the end of the study. Method of measurement: Blood test is done to determine the serum levels of the liver enzymes alanine transaminase and aspartate transaminase.;Decreased liver grade. Timepoint: Measurement three days after the end of the study. Method of measurement: Liver grade with ultrasound device from Samsung Korea WS80A model.;Decreased blood lipid profile. Timepoint: Measurement three days after the end of the study. Method of measurement: Blood sample to determine the amount of blood lipid profile by BT 2500 analyzer and 3000 rpm centrifuge in 5 minutes with Behdad machine made in Iran and standard kits of Pars Azmoon company.;Increase motor performance. Timepoint: Measurement three days after the end of the study. Method of measurement: Motor function is performed by physical fitness tests (sitting position, step test, quadratic agility, stork balance and flexibility). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Taheri Dilatabadi
Shahed University
Outcome results
None listed